About the Authors
- Calpurnia Jayakumar
-
Affiliation Department of Medicine and Vascular Biology Center, Georgia Health Sciences University, Augusta, Georgia, United States of America
- Punithavathi Ranganathan
-
Affiliation Department of Medicine and Vascular Biology Center, Georgia Health Sciences University, Augusta, Georgia, United States of America
- Prasad Devarajan
-
Affiliation Department of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, Ohio, United States of America
- Catherine D. Krawczeski
-
Affiliation Heart Institute, Cincinnati Children’s Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, Ohio, United States of America
- Stephen Looney
-
Affiliation Department of Biostatistics, Georgia Health Sciences University, Augusta, Georgia, United States of America
- Ganesan Ramesh
-
* E-mail: gramesh@georgiahealth.edu
Affiliation Department of Medicine and Vascular Biology Center, Georgia Health Sciences University, Augusta, Georgia, United States of America
Competing Interests
The authors have the following interests. Dr. Ramesh and Georgia Health Sciences University have submitted a provisional patent application for the use of urine semaphorin 3A for the early diagnosis of AKI. Dr. Devarajan is a co-inventor on patents related to NGAL as a biomarker of AKI, and is a consultant to Abbott Diagnostics and Biosite, Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: GR. Performed the experiments: CJ PR GR. Analyzed the data: SL PD. Contributed reagents/materials/analysis tools: PD CDK. Wrote the paper: CJ GR PD SL.